Tuesday, April 20, 2021 12:39:40 PM
NRX should be making their applications for their review as a Type A (appeal) or Type B for EOP2/3 because it apparently is 4 week wait. After data submissions. I guess IND and NDA are different than EUA??
Looks like we / some investors only saw it. TIME TO MAKE MANY PRS!!!IMHFO!!!
Butt,,, it also seems that RLF/NRX "Management" teams are more involved in the recent pissing match, so far.
RLF SHOULD have this Data NOW.
Dumped some and bought some back.
BUUTTT, I certainly DO NOT UNDERSTAND THESE CRAZY company's Managements REMARKABLY DUMB?PUBLIC?HINDSIGHTED?CONTRAIRIAN?STUPID?UNCOOTH?UNPLANNED?REACTIVE not PROACTIVE paths and actions.
NRX/P surely knew the data was IMMINENT, so why the Tree-shake Pissing match.
At least we KNOW the Data is confirmed and WE CAN HOPE it is being expedited...
Plagiarized link...
https://www.fda.gov/media/72253/download
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM